Organization

SN Bioscience

1 clinical trial

Clinical trial

A Phase I, Open-Label, Dose-finding Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenously Infused SNB-101(as SN-38) in Patients With Advanced Solid Tumors

Status: Not yet recruiting, Estimated PCD: 2024-12-31